Carotid Ultrasound in the Evaluation of Heart Failure (CUE-HF)
This study has been completed.
Sponsor:
New York University School of Medicine
Collaborator:
New York Cardiac Center Foundation
Information provided by:
New York University School of Medicine
ClinicalTrials.gov Identifier:
NCT00810550
First received: December 17, 2008
Last updated: NA
Last verified: December 2008
History: No changes posted
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Coronary artery disease (CAD, cholesterol plaque buildup in the heart arteries) is the most common cause of left ventricular systolic dysfunction (weakening of the heart muscle). The standard test to find coronary artery disease is coronary angiography. This test is highly accurate but is invasive and carries a small risk of complications. This study investigates ultrasound of the carotid (neck) arteries as a screening test for severe coronary artery disease as a cause of left ventricular systolic dysfunction. It is hypothesized that carotid ultrasound will have excellent negative predictive value for severe CAD.
| Condition | Intervention |
|---|---|
|
Coronary Artery Disease Cardiomyopathy Heart Failure |
Procedure: Carotid ultrasound |
| Study Type: | Interventional |
| Study Design: | Intervention Model: Single Group Assignment Primary Purpose: Diagnostic |
| Official Title: | Carotid Ultrasound in the Evaluation of Heart Failure |
Resource links provided by NLM:
Further study details as provided by New York University School of Medicine:
Primary Outcome Measures:
- Diagnostic accuracy for severe CAD
Secondary Outcome Measures:
- Diagnostic accuracy for significant CAD
| Enrollment: | 150 |
| Study Start Date: | October 2005 |
| Study Completion Date: | December 2008 |
| Primary Completion Date: | December 2008 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
| Experimental: LV systolic dysfunction |
Procedure: Carotid ultrasound
Measurement of intima-media thickness
|
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- LVEF 40% or less
Exclusion Criteria:
- Prior diagnosis of coronary or carotid obstructive atherosclerosis
Contacts and Locations
No Contacts or Locations Provided
More Information
No publications provided by New York University School of Medicine
Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
| Responsible Party: | Harmony Reynolds, NYU School of Medicine |
| ClinicalTrials.gov Identifier: | NCT00810550 History of Changes |
| Other Study ID Numbers: | NYCC CUE-HF |
| Study First Received: | December 17, 2008 |
| Last Updated: | December 17, 2008 |
| Health Authority: | United States: Institutional Review Board |
Additional relevant MeSH terms:
|
Coronary Artery Disease Myocardial Ischemia Coronary Disease Heart Failure Cardiomyopathies |
Heart Diseases Cardiovascular Diseases Arteriosclerosis Arterial Occlusive Diseases Vascular Diseases |
ClinicalTrials.gov processed this record on June 17, 2013